Use of IL-6 antagonists in combination with steroids to enhance apoptosis

Details for Australian Patent Application No. 2004210626 (hide)

Owner Centocor Inc.

Inventors Trikha, Mohit; Zaki, Mohamed

Agent Shelston IP

Pub. Number AU-A-2004210626

PCT Pub. Number WO2004/071404

Priority 60/444,843 04.02.03 US

Filing date 16 January 2004

Wipo publication date 26 August 2004

International Classifications

C07K 016/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

11 August 2005 PCT application entered the National Phase

  PCT publication WO2004/071404 Priority application(s): WO2004/071404

7 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004210627-Opthalmic talbot-moire wavefront sensor

2004210625-Short immunomodulatory oligonucleotides